- Home
- Share
- Forum
- General forums
- Health and Medical News
- Should the FDA approve a drug despite uncertainties about its effectiveness?
Should the FDA approve a drug despite uncertainties about its effectiveness?
- 5 views
- 0 support
- 2 comments
All comments
seattlelife
seattlelife
Last activity on 11/15/2022 at 10:22 AM
Joined in 2018
14 comments posted | 1 in the Health and Medical News group
Rewards
-
Contributor
-
Messenger
-
Explorer
Hi @LizziB
This is an interesting topic. Yes I think it would be okay for them to release drugs without a lot of information, I kind of already feel they do this. Also, for rare diseases, they probably don't have enough people to trial it on so how would they ever get any new drugs.
But that's just my opinion...
Close all
See the responses
LizziB
Community managerGood advisor
LizziB
Community manager
Last activity on 04/21/2024 at 8:17 PM
Joined in 2022
603 comments posted | 6 in the Health and Medical News group
24 of their responses were helpful to members
Rewards
-
Good Advisor
-
Contributor
-
Messenger
-
Explorer
-
Friend
HI @seattlelife
How are you today?
Thank you for your opinion. I think many people don't understand how complicated clinical trials can be and how hard it is to recruit participants. I will tag a few other members who may suffer from or know someone suffering from a rare condition to see if they have other thoughts on this topic.
@AlphaBehemonth @TCoffey @Funfun111 @Maryjean @Andagain @Nurscutie @Nylahkay21 @KO_Migraine @Susan-Jane @Tnewman @Sarah1004 @Mustang08 @Natassia @cathybuffalo @Bearbo @Skinsfan23693 @Twettybird @PaulaKay
Should the FDA approve drugs that may help patients suffering from chronic or degenerative diseases without extensive trials? Would you take a drug with FDA approval but few trial participants? What do you think?
Take care,
Lizzi
See the signature
LizziB
Hide the responses
Give your opinion
Articles to discover...
12/21/2024 | Nutrition
Anti-fatigue foods: How can you boost your energy naturally?
02/20/2019 | Advice
Cigarettes VS e-cigarettes: an update on the consumption and pitfalls to avoid
03/11/2019 | News
04/15/2019 | Advice
02/14/2019 | Advice
Subscribe
You wish to be notified of new comments
You have been subscribed
LizziB
Community managerGood advisor
LizziB
Community manager
Last activity on 04/21/2024 at 8:17 PM
Joined in 2022
603 comments posted | 6 in the Health and Medical News group
24 of their responses were helpful to members
Rewards
Good Advisor
Contributor
Messenger
Explorer
Friend
Hi everyone,
How are you today?
The Food and Drug Administration (FDA) has been in the news recently about whether they will approve a drug for the debilitating disease Amyotrophic lateral sclerosis (ALS). The reason why this is controversial is because advisors have recommended to approve the drug despite uncertainties about its effectiveness. The only trial contained less than 200 participants. But it could be very beneficial for those suffering from ALS seeing as it will be the first new drug for the disease in 5 years.
Should the FDA approve drugs that may help patients suffering from chronic or degenerative diseases without extensive trials? Would you take a drug with FDA approval but few trial participants? What do you think?
Please share your experiences and thoughts!
Take care,
Lizzi